Global Oncology Therapeutic Drug Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.
Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
LPI (LP Information)' newest research report, the “Oncology Therapeutic Drug Industry Forecast” looks at past sales and reviews total world Oncology Therapeutic Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Oncology Therapeutic Drug sales for 2023 through 2029. With Oncology Therapeutic Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology Therapeutic Drug industry.
This Insight Report provides a comprehensive analysis of the global Oncology Therapeutic Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oncology Therapeutic Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Oncology Therapeutic Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology Therapeutic Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology Therapeutic Drug.
The global Oncology Therapeutic Drug market size is projected to grow from US$ 193150 million in 2022 to US$ 337490 million in 2029; it is expected to grow at a CAGR of 337490 from 2023 to 2029.
The industry's leading producers include Roche, Celgene and Novartis, which together account for 35% of their revenues. By region, North America had the highest share of income, at 43%.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Therapeutic Drug market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Oncology Therapeutic Drug market?
What factors are driving Oncology Therapeutic Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oncology Therapeutic Drug market opportunities vary by end market size?
How does Oncology Therapeutic Drug break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.
Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
LPI (LP Information)' newest research report, the “Oncology Therapeutic Drug Industry Forecast” looks at past sales and reviews total world Oncology Therapeutic Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Oncology Therapeutic Drug sales for 2023 through 2029. With Oncology Therapeutic Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology Therapeutic Drug industry.
This Insight Report provides a comprehensive analysis of the global Oncology Therapeutic Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oncology Therapeutic Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Oncology Therapeutic Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology Therapeutic Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology Therapeutic Drug.
The global Oncology Therapeutic Drug market size is projected to grow from US$ 193150 million in 2022 to US$ 337490 million in 2029; it is expected to grow at a CAGR of 337490 from 2023 to 2029.
The industry's leading producers include Roche, Celgene and Novartis, which together account for 35% of their revenues. By region, North America had the highest share of income, at 43%.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Therapeutic Drug market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Hormonal Therapy
- Others
- Breast Cancer
- Gastrointestinal Cancer
- Prostate Cancer
- Respiratory and Lung Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AbbVie
- Amgen
- Astellas Pharma
- AstraZeneca
- Bayer
- Biogen
- Bristol Myers Squibb
- Celgene
- Eisai
- Eli Lilly and Company
- Gilead Sciences
- Ipsen
- Johnson and Johnson
- Merck
- Novartis
- Otsuka Pharmaceutical
- Pfizer
- F. Hoffmann-La Roche
- Sanofi
- Takeda Pharmaceutical
- Teva Pharmaceutical Industries
What is the 10-year outlook for the global Oncology Therapeutic Drug market?
What factors are driving Oncology Therapeutic Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oncology Therapeutic Drug market opportunities vary by end market size?
How does Oncology Therapeutic Drug break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology Therapeutic Drug Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Oncology Therapeutic Drug by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Oncology Therapeutic Drug by Country/Region, 2018, 2022 & 2029
2.2 Oncology Therapeutic Drug Segment by Type
2.2.1 Chemotherapy
2.2.2 Targeted Therapy
2.2.3 Immunotherapy
2.2.4 Hormonal Therapy
2.2.5 Others
2.3 Oncology Therapeutic Drug Sales by Type
2.3.1 Global Oncology Therapeutic Drug Sales Market Share by Type (2018-2023)
2.3.2 Global Oncology Therapeutic Drug Revenue and Market Share by Type (2018-2023)
2.3.3 Global Oncology Therapeutic Drug Sale Price by Type (2018-2023)
2.4 Oncology Therapeutic Drug Segment by Application
2.4.1 Breast Cancer
2.4.2 Gastrointestinal Cancer
2.4.3 Prostate Cancer
2.4.4 Respiratory and Lung Cancer
2.4.5 Others
2.5 Oncology Therapeutic Drug Sales by Application
2.5.1 Global Oncology Therapeutic Drug Sale Market Share by Application (2018-2023)
2.5.2 Global Oncology Therapeutic Drug Revenue and Market Share by Application (2018-2023)
2.5.3 Global Oncology Therapeutic Drug Sale Price by Application (2018-2023)
3 GLOBAL ONCOLOGY THERAPEUTIC DRUG BY COMPANY
3.1 Global Oncology Therapeutic Drug Breakdown Data by Company
3.1.1 Global Oncology Therapeutic Drug Annual Sales by Company (2018-2023)
3.1.2 Global Oncology Therapeutic Drug Sales Market Share by Company (2018-2023)
3.2 Global Oncology Therapeutic Drug Annual Revenue by Company (2018-2023)
3.2.1 Global Oncology Therapeutic Drug Revenue by Company (2018-2023)
3.2.2 Global Oncology Therapeutic Drug Revenue Market Share by Company (2018-2023)
3.3 Global Oncology Therapeutic Drug Sale Price by Company
3.4 Key Manufacturers Oncology Therapeutic Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oncology Therapeutic Drug Product Location Distribution
3.4.2 Players Oncology Therapeutic Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ONCOLOGY THERAPEUTIC DRUG BY GEOGRAPHIC REGION
4.1 World Historic Oncology Therapeutic Drug Market Size by Geographic Region (2018-2023)
4.1.1 Global Oncology Therapeutic Drug Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Oncology Therapeutic Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Oncology Therapeutic Drug Market Size by Country/Region (2018-2023)
4.2.1 Global Oncology Therapeutic Drug Annual Sales by Country/Region (2018-2023)
4.2.2 Global Oncology Therapeutic Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas Oncology Therapeutic Drug Sales Growth
4.4 APAC Oncology Therapeutic Drug Sales Growth
4.5 Europe Oncology Therapeutic Drug Sales Growth
4.6 Middle East & Africa Oncology Therapeutic Drug Sales Growth
5 AMERICAS
5.1 Americas Oncology Therapeutic Drug Sales by Country
5.1.1 Americas Oncology Therapeutic Drug Sales by Country (2018-2023)
5.1.2 Americas Oncology Therapeutic Drug Revenue by Country (2018-2023)
5.2 Americas Oncology Therapeutic Drug Sales by Type
5.3 Americas Oncology Therapeutic Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Therapeutic Drug Sales by Region
6.1.1 APAC Oncology Therapeutic Drug Sales by Region (2018-2023)
6.1.2 APAC Oncology Therapeutic Drug Revenue by Region (2018-2023)
6.2 APAC Oncology Therapeutic Drug Sales by Type
6.3 APAC Oncology Therapeutic Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oncology Therapeutic Drug by Country
7.1.1 Europe Oncology Therapeutic Drug Sales by Country (2018-2023)
7.1.2 Europe Oncology Therapeutic Drug Revenue by Country (2018-2023)
7.2 Europe Oncology Therapeutic Drug Sales by Type
7.3 Europe Oncology Therapeutic Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology Therapeutic Drug by Country
8.1.1 Middle East & Africa Oncology Therapeutic Drug Sales by Country (2018-2023)
8.1.2 Middle East & Africa Oncology Therapeutic Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa Oncology Therapeutic Drug Sales by Type
8.3 Middle East & Africa Oncology Therapeutic Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oncology Therapeutic Drug
10.3 Manufacturing Process Analysis of Oncology Therapeutic Drug
10.4 Industry Chain Structure of Oncology Therapeutic Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oncology Therapeutic Drug Distributors
11.3 Oncology Therapeutic Drug Customer
12 WORLD FORECAST REVIEW FOR ONCOLOGY THERAPEUTIC DRUG BY GEOGRAPHIC REGION
12.1 Global Oncology Therapeutic Drug Market Size Forecast by Region
12.1.1 Global Oncology Therapeutic Drug Forecast by Region (2024-2029)
12.1.2 Global Oncology Therapeutic Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oncology Therapeutic Drug Forecast by Type
12.7 Global Oncology Therapeutic Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Oncology Therapeutic Drug Product Portfolios and Specifications
13.1.3 AbbVie Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Amgen
13.2.1 Amgen Company Information
13.2.2 Amgen Oncology Therapeutic Drug Product Portfolios and Specifications
13.2.3 Amgen Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Amgen Main Business Overview
13.2.5 Amgen Latest Developments
13.3 Astellas Pharma
13.3.1 Astellas Pharma Company Information
13.3.2 Astellas Pharma Oncology Therapeutic Drug Product Portfolios and Specifications
13.3.3 Astellas Pharma Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Astellas Pharma Main Business Overview
13.3.5 Astellas Pharma Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca Oncology Therapeutic Drug Product Portfolios and Specifications
13.4.3 AstraZeneca Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Bayer
13.5.1 Bayer Company Information
13.5.2 Bayer Oncology Therapeutic Drug Product Portfolios and Specifications
13.5.3 Bayer Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Bayer Main Business Overview
13.5.5 Bayer Latest Developments
13.6 Biogen
13.6.1 Biogen Company Information
13.6.2 Biogen Oncology Therapeutic Drug Product Portfolios and Specifications
13.6.3 Biogen Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Biogen Main Business Overview
13.6.5 Biogen Latest Developments
13.7 Bristol Myers Squibb
13.7.1 Bristol Myers Squibb Company Information
13.7.2 Bristol Myers Squibb Oncology Therapeutic Drug Product Portfolios and Specifications
13.7.3 Bristol Myers Squibb Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bristol Myers Squibb Main Business Overview
13.7.5 Bristol Myers Squibb Latest Developments
13.8 Celgene
13.8.1 Celgene Company Information
13.8.2 Celgene Oncology Therapeutic Drug Product Portfolios and Specifications
13.8.3 Celgene Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Celgene Main Business Overview
13.8.5 Celgene Latest Developments
13.9 Eisai
13.9.1 Eisai Company Information
13.9.2 Eisai Oncology Therapeutic Drug Product Portfolios and Specifications
13.9.3 Eisai Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Eisai Main Business Overview
13.9.5 Eisai Latest Developments
13.10 Eli Lilly and Company
13.10.1 Eli Lilly and Company Company Information
13.10.2 Eli Lilly and Company Oncology Therapeutic Drug Product Portfolios and Specifications
13.10.3 Eli Lilly and Company Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Eli Lilly and Company Main Business Overview
13.10.5 Eli Lilly and Company Latest Developments
13.11 Gilead Sciences
13.11.1 Gilead Sciences Company Information
13.11.2 Gilead Sciences Oncology Therapeutic Drug Product Portfolios and Specifications
13.11.3 Gilead Sciences Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Gilead Sciences Main Business Overview
13.11.5 Gilead Sciences Latest Developments
13.12 Ipsen
13.12.1 Ipsen Company Information
13.12.2 Ipsen Oncology Therapeutic Drug Product Portfolios and Specifications
13.12.3 Ipsen Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Ipsen Main Business Overview
13.12.5 Ipsen Latest Developments
13.13 Johnson and Johnson
13.13.1 Johnson and Johnson Company Information
13.13.2 Johnson and Johnson Oncology Therapeutic Drug Product Portfolios and Specifications
13.13.3 Johnson and Johnson Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Johnson and Johnson Main Business Overview
13.13.5 Johnson and Johnson Latest Developments
13.14 Merck
13.14.1 Merck Company Information
13.14.2 Merck Oncology Therapeutic Drug Product Portfolios and Specifications
13.14.3 Merck Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Merck Main Business Overview
13.14.5 Merck Latest Developments
13.15 Novartis
13.15.1 Novartis Company Information
13.15.2 Novartis Oncology Therapeutic Drug Product Portfolios and Specifications
13.15.3 Novartis Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Novartis Main Business Overview
13.15.5 Novartis Latest Developments
13.16 Otsuka Pharmaceutical
13.16.1 Otsuka Pharmaceutical Company Information
13.16.2 Otsuka Pharmaceutical Oncology Therapeutic Drug Product Portfolios and Specifications
13.16.3 Otsuka Pharmaceutical Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Otsuka Pharmaceutical Main Business Overview
13.16.5 Otsuka Pharmaceutical Latest Developments
13.17 Pfizer
13.17.1 Pfizer Company Information
13.17.2 Pfizer Oncology Therapeutic Drug Product Portfolios and Specifications
13.17.3 Pfizer Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Pfizer Main Business Overview
13.17.5 Pfizer Latest Developments
13.18 F. Hoffmann-La Roche
13.18.1 F. Hoffmann-La Roche Company Information
13.18.2 F. Hoffmann-La Roche Oncology Therapeutic Drug Product Portfolios and Specifications
13.18.3 F. Hoffmann-La Roche Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 F. Hoffmann-La Roche Main Business Overview
13.18.5 F. Hoffmann-La Roche Latest Developments
13.19 Sanofi
13.19.1 Sanofi Company Information
13.19.2 Sanofi Oncology Therapeutic Drug Product Portfolios and Specifications
13.19.3 Sanofi Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Sanofi Main Business Overview
13.19.5 Sanofi Latest Developments
13.20 Takeda Pharmaceutical
13.20.1 Takeda Pharmaceutical Company Information
13.20.2 Takeda Pharmaceutical Oncology Therapeutic Drug Product Portfolios and Specifications
13.20.3 Takeda Pharmaceutical Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Takeda Pharmaceutical Main Business Overview
13.20.5 Takeda Pharmaceutical Latest Developments
13.21 Teva Pharmaceutical Industries
13.21.1 Teva Pharmaceutical Industries Company Information
13.21.2 Teva Pharmaceutical Industries Oncology Therapeutic Drug Product Portfolios and Specifications
13.21.3 Teva Pharmaceutical Industries Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Teva Pharmaceutical Industries Main Business Overview
13.21.5 Teva Pharmaceutical Industries Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology Therapeutic Drug Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Oncology Therapeutic Drug by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Oncology Therapeutic Drug by Country/Region, 2018, 2022 & 2029
2.2 Oncology Therapeutic Drug Segment by Type
2.2.1 Chemotherapy
2.2.2 Targeted Therapy
2.2.3 Immunotherapy
2.2.4 Hormonal Therapy
2.2.5 Others
2.3 Oncology Therapeutic Drug Sales by Type
2.3.1 Global Oncology Therapeutic Drug Sales Market Share by Type (2018-2023)
2.3.2 Global Oncology Therapeutic Drug Revenue and Market Share by Type (2018-2023)
2.3.3 Global Oncology Therapeutic Drug Sale Price by Type (2018-2023)
2.4 Oncology Therapeutic Drug Segment by Application
2.4.1 Breast Cancer
2.4.2 Gastrointestinal Cancer
2.4.3 Prostate Cancer
2.4.4 Respiratory and Lung Cancer
2.4.5 Others
2.5 Oncology Therapeutic Drug Sales by Application
2.5.1 Global Oncology Therapeutic Drug Sale Market Share by Application (2018-2023)
2.5.2 Global Oncology Therapeutic Drug Revenue and Market Share by Application (2018-2023)
2.5.3 Global Oncology Therapeutic Drug Sale Price by Application (2018-2023)
3 GLOBAL ONCOLOGY THERAPEUTIC DRUG BY COMPANY
3.1 Global Oncology Therapeutic Drug Breakdown Data by Company
3.1.1 Global Oncology Therapeutic Drug Annual Sales by Company (2018-2023)
3.1.2 Global Oncology Therapeutic Drug Sales Market Share by Company (2018-2023)
3.2 Global Oncology Therapeutic Drug Annual Revenue by Company (2018-2023)
3.2.1 Global Oncology Therapeutic Drug Revenue by Company (2018-2023)
3.2.2 Global Oncology Therapeutic Drug Revenue Market Share by Company (2018-2023)
3.3 Global Oncology Therapeutic Drug Sale Price by Company
3.4 Key Manufacturers Oncology Therapeutic Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oncology Therapeutic Drug Product Location Distribution
3.4.2 Players Oncology Therapeutic Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ONCOLOGY THERAPEUTIC DRUG BY GEOGRAPHIC REGION
4.1 World Historic Oncology Therapeutic Drug Market Size by Geographic Region (2018-2023)
4.1.1 Global Oncology Therapeutic Drug Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Oncology Therapeutic Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Oncology Therapeutic Drug Market Size by Country/Region (2018-2023)
4.2.1 Global Oncology Therapeutic Drug Annual Sales by Country/Region (2018-2023)
4.2.2 Global Oncology Therapeutic Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas Oncology Therapeutic Drug Sales Growth
4.4 APAC Oncology Therapeutic Drug Sales Growth
4.5 Europe Oncology Therapeutic Drug Sales Growth
4.6 Middle East & Africa Oncology Therapeutic Drug Sales Growth
5 AMERICAS
5.1 Americas Oncology Therapeutic Drug Sales by Country
5.1.1 Americas Oncology Therapeutic Drug Sales by Country (2018-2023)
5.1.2 Americas Oncology Therapeutic Drug Revenue by Country (2018-2023)
5.2 Americas Oncology Therapeutic Drug Sales by Type
5.3 Americas Oncology Therapeutic Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Therapeutic Drug Sales by Region
6.1.1 APAC Oncology Therapeutic Drug Sales by Region (2018-2023)
6.1.2 APAC Oncology Therapeutic Drug Revenue by Region (2018-2023)
6.2 APAC Oncology Therapeutic Drug Sales by Type
6.3 APAC Oncology Therapeutic Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oncology Therapeutic Drug by Country
7.1.1 Europe Oncology Therapeutic Drug Sales by Country (2018-2023)
7.1.2 Europe Oncology Therapeutic Drug Revenue by Country (2018-2023)
7.2 Europe Oncology Therapeutic Drug Sales by Type
7.3 Europe Oncology Therapeutic Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology Therapeutic Drug by Country
8.1.1 Middle East & Africa Oncology Therapeutic Drug Sales by Country (2018-2023)
8.1.2 Middle East & Africa Oncology Therapeutic Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa Oncology Therapeutic Drug Sales by Type
8.3 Middle East & Africa Oncology Therapeutic Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oncology Therapeutic Drug
10.3 Manufacturing Process Analysis of Oncology Therapeutic Drug
10.4 Industry Chain Structure of Oncology Therapeutic Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oncology Therapeutic Drug Distributors
11.3 Oncology Therapeutic Drug Customer
12 WORLD FORECAST REVIEW FOR ONCOLOGY THERAPEUTIC DRUG BY GEOGRAPHIC REGION
12.1 Global Oncology Therapeutic Drug Market Size Forecast by Region
12.1.1 Global Oncology Therapeutic Drug Forecast by Region (2024-2029)
12.1.2 Global Oncology Therapeutic Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oncology Therapeutic Drug Forecast by Type
12.7 Global Oncology Therapeutic Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Oncology Therapeutic Drug Product Portfolios and Specifications
13.1.3 AbbVie Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Amgen
13.2.1 Amgen Company Information
13.2.2 Amgen Oncology Therapeutic Drug Product Portfolios and Specifications
13.2.3 Amgen Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Amgen Main Business Overview
13.2.5 Amgen Latest Developments
13.3 Astellas Pharma
13.3.1 Astellas Pharma Company Information
13.3.2 Astellas Pharma Oncology Therapeutic Drug Product Portfolios and Specifications
13.3.3 Astellas Pharma Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Astellas Pharma Main Business Overview
13.3.5 Astellas Pharma Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca Oncology Therapeutic Drug Product Portfolios and Specifications
13.4.3 AstraZeneca Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Bayer
13.5.1 Bayer Company Information
13.5.2 Bayer Oncology Therapeutic Drug Product Portfolios and Specifications
13.5.3 Bayer Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Bayer Main Business Overview
13.5.5 Bayer Latest Developments
13.6 Biogen
13.6.1 Biogen Company Information
13.6.2 Biogen Oncology Therapeutic Drug Product Portfolios and Specifications
13.6.3 Biogen Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Biogen Main Business Overview
13.6.5 Biogen Latest Developments
13.7 Bristol Myers Squibb
13.7.1 Bristol Myers Squibb Company Information
13.7.2 Bristol Myers Squibb Oncology Therapeutic Drug Product Portfolios and Specifications
13.7.3 Bristol Myers Squibb Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bristol Myers Squibb Main Business Overview
13.7.5 Bristol Myers Squibb Latest Developments
13.8 Celgene
13.8.1 Celgene Company Information
13.8.2 Celgene Oncology Therapeutic Drug Product Portfolios and Specifications
13.8.3 Celgene Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Celgene Main Business Overview
13.8.5 Celgene Latest Developments
13.9 Eisai
13.9.1 Eisai Company Information
13.9.2 Eisai Oncology Therapeutic Drug Product Portfolios and Specifications
13.9.3 Eisai Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Eisai Main Business Overview
13.9.5 Eisai Latest Developments
13.10 Eli Lilly and Company
13.10.1 Eli Lilly and Company Company Information
13.10.2 Eli Lilly and Company Oncology Therapeutic Drug Product Portfolios and Specifications
13.10.3 Eli Lilly and Company Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Eli Lilly and Company Main Business Overview
13.10.5 Eli Lilly and Company Latest Developments
13.11 Gilead Sciences
13.11.1 Gilead Sciences Company Information
13.11.2 Gilead Sciences Oncology Therapeutic Drug Product Portfolios and Specifications
13.11.3 Gilead Sciences Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Gilead Sciences Main Business Overview
13.11.5 Gilead Sciences Latest Developments
13.12 Ipsen
13.12.1 Ipsen Company Information
13.12.2 Ipsen Oncology Therapeutic Drug Product Portfolios and Specifications
13.12.3 Ipsen Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Ipsen Main Business Overview
13.12.5 Ipsen Latest Developments
13.13 Johnson and Johnson
13.13.1 Johnson and Johnson Company Information
13.13.2 Johnson and Johnson Oncology Therapeutic Drug Product Portfolios and Specifications
13.13.3 Johnson and Johnson Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Johnson and Johnson Main Business Overview
13.13.5 Johnson and Johnson Latest Developments
13.14 Merck
13.14.1 Merck Company Information
13.14.2 Merck Oncology Therapeutic Drug Product Portfolios and Specifications
13.14.3 Merck Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Merck Main Business Overview
13.14.5 Merck Latest Developments
13.15 Novartis
13.15.1 Novartis Company Information
13.15.2 Novartis Oncology Therapeutic Drug Product Portfolios and Specifications
13.15.3 Novartis Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Novartis Main Business Overview
13.15.5 Novartis Latest Developments
13.16 Otsuka Pharmaceutical
13.16.1 Otsuka Pharmaceutical Company Information
13.16.2 Otsuka Pharmaceutical Oncology Therapeutic Drug Product Portfolios and Specifications
13.16.3 Otsuka Pharmaceutical Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Otsuka Pharmaceutical Main Business Overview
13.16.5 Otsuka Pharmaceutical Latest Developments
13.17 Pfizer
13.17.1 Pfizer Company Information
13.17.2 Pfizer Oncology Therapeutic Drug Product Portfolios and Specifications
13.17.3 Pfizer Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Pfizer Main Business Overview
13.17.5 Pfizer Latest Developments
13.18 F. Hoffmann-La Roche
13.18.1 F. Hoffmann-La Roche Company Information
13.18.2 F. Hoffmann-La Roche Oncology Therapeutic Drug Product Portfolios and Specifications
13.18.3 F. Hoffmann-La Roche Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 F. Hoffmann-La Roche Main Business Overview
13.18.5 F. Hoffmann-La Roche Latest Developments
13.19 Sanofi
13.19.1 Sanofi Company Information
13.19.2 Sanofi Oncology Therapeutic Drug Product Portfolios and Specifications
13.19.3 Sanofi Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Sanofi Main Business Overview
13.19.5 Sanofi Latest Developments
13.20 Takeda Pharmaceutical
13.20.1 Takeda Pharmaceutical Company Information
13.20.2 Takeda Pharmaceutical Oncology Therapeutic Drug Product Portfolios and Specifications
13.20.3 Takeda Pharmaceutical Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Takeda Pharmaceutical Main Business Overview
13.20.5 Takeda Pharmaceutical Latest Developments
13.21 Teva Pharmaceutical Industries
13.21.1 Teva Pharmaceutical Industries Company Information
13.21.2 Teva Pharmaceutical Industries Oncology Therapeutic Drug Product Portfolios and Specifications
13.21.3 Teva Pharmaceutical Industries Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Teva Pharmaceutical Industries Main Business Overview
13.21.5 Teva Pharmaceutical Industries Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oncology Therapeutic Drug Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Oncology Therapeutic Drug Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Chemotherapy
Table 4. Major Players of Targeted Therapy
Table 5. Major Players of Immunotherapy
Table 6. Major Players of Hormonal Therapy
Table 7. Major Players of Others
Table 8. Global Oncology Therapeutic Drug Sales by Type (2018-2023) & (K Units)
Table 9. Global Oncology Therapeutic Drug Sales Market Share by Type (2018-2023)
Table 10. Global Oncology Therapeutic Drug Revenue by Type (2018-2023) & ($ million)
Table 11. Global Oncology Therapeutic Drug Revenue Market Share by Type (2018-2023)
Table 12. Global Oncology Therapeutic Drug Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Oncology Therapeutic Drug Sales by Application (2018-2023) & (K Units)
Table 14. Global Oncology Therapeutic Drug Sales Market Share by Application (2018-2023)
Table 15. Global Oncology Therapeutic Drug Revenue by Application (2018-2023)
Table 16. Global Oncology Therapeutic Drug Revenue Market Share by Application (2018-2023)
Table 17. Global Oncology Therapeutic Drug Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Oncology Therapeutic Drug Sales by Company (2018-2023) & (K Units)
Table 19. Global Oncology Therapeutic Drug Sales Market Share by Company (2018-2023)
Table 20. Global Oncology Therapeutic Drug Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Oncology Therapeutic Drug Revenue Market Share by Company (2018-2023)
Table 22. Global Oncology Therapeutic Drug Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Oncology Therapeutic Drug Producing Area Distribution and Sales Area
Table 24. Players Oncology Therapeutic Drug Products Offered
Table 25. Oncology Therapeutic Drug Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Oncology Therapeutic Drug Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Oncology Therapeutic Drug Sales Market Share Geographic Region (2018-2023)
Table 30. Global Oncology Therapeutic Drug Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Oncology Therapeutic Drug Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Oncology Therapeutic Drug Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Oncology Therapeutic Drug Sales Market Share by Country/Region (2018-2023)
Table 34. Global Oncology Therapeutic Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Oncology Therapeutic Drug Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Oncology Therapeutic Drug Sales by Country (2018-2023) & (K Units)
Table 37. Americas Oncology Therapeutic Drug Sales Market Share by Country (2018-2023)
Table 38. Americas Oncology Therapeutic Drug Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Oncology Therapeutic Drug Revenue Market Share by Country (2018-2023)
Table 40. Americas Oncology Therapeutic Drug Sales by Type (2018-2023) & (K Units)
Table 41. Americas Oncology Therapeutic Drug Sales by Application (2018-2023) & (K Units)
Table 42. APAC Oncology Therapeutic Drug Sales by Region (2018-2023) & (K Units)
Table 43. APAC Oncology Therapeutic Drug Sales Market Share by Region (2018-2023)
Table 44. APAC Oncology Therapeutic Drug Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Oncology Therapeutic Drug Revenue Market Share by Region (2018-2023)
Table 46. APAC Oncology Therapeutic Drug Sales by Type (2018-2023) & (K Units)
Table 47. APAC Oncology Therapeutic Drug Sales by Application (2018-2023) & (K Units)
Table 48. Europe Oncology Therapeutic Drug Sales by Country (2018-2023) & (K Units)
Table 49. Europe Oncology Therapeutic Drug Sales Market Share by Country (2018-2023)
Table 50. Europe Oncology Therapeutic Drug Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Oncology Therapeutic Drug Revenue Market Share by Country (2018-2023)
Table 52. Europe Oncology Therapeutic Drug Sales by Type (2018-2023) & (K Units)
Table 53. Europe Oncology Therapeutic Drug Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Oncology Therapeutic Drug Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Oncology Therapeutic Drug Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Oncology Therapeutic Drug Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Oncology Therapeutic Drug Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Oncology Therapeutic Drug Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Oncology Therapeutic Drug Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Oncology Therapeutic Drug
Table 61. Key Market Challenges & Risks of Oncology Therapeutic Drug
Table 62. Key Industry Trends of Oncology Therapeutic Drug
Table 63. Oncology Therapeutic Drug Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Oncology Therapeutic Drug Distributors List
Table 66. Oncology Therapeutic Drug Customer List
Table 67. Global Oncology Therapeutic Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Oncology Therapeutic Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Oncology Therapeutic Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Oncology Therapeutic Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Oncology Therapeutic Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Oncology Therapeutic Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Oncology Therapeutic Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Oncology Therapeutic Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Oncology Therapeutic Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Oncology Therapeutic Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Oncology Therapeutic Drug Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Oncology Therapeutic Drug Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Oncology Therapeutic Drug Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Oncology Therapeutic Drug Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. AbbVie Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. AbbVie Oncology Therapeutic Drug Product Portfolios and Specifications
Table 83. AbbVie Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. AbbVie Main Business
Table 85. AbbVie Latest Developments
Table 86. Amgen Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Amgen Oncology Therapeutic Drug Product Portfolios and Specifications
Table 88. Amgen Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Amgen Main Business
Table 90. Amgen Latest Developments
Table 91. Astellas Pharma Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. Astellas Pharma Oncology Therapeutic Drug Product Portfolios and Specifications
Table 93. Astellas Pharma Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Astellas Pharma Main Business
Table 95. Astellas Pharma Latest Developments
Table 96. AstraZeneca Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. AstraZeneca Oncology Therapeutic Drug Product Portfolios and Specifications
Table 98. AstraZeneca Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. AstraZeneca Main Business
Table 100. AstraZeneca Latest Developments
Table 101. Bayer Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. Bayer Oncology Therapeutic Drug Product Portfolios and Specifications
Table 103. Bayer Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Bayer Main Business
Table 105. Bayer Latest Developments
Table 106. Biogen Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Biogen Oncology Therapeutic Drug Product Portfolios and Specifications
Table 108. Biogen Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Biogen Main Business
Table 110. Biogen Latest Developments
Table 111. Bristol Myers Squibb Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. Bristol Myers Squibb Oncology Therapeutic Drug Product Portfolios and Specifications
Table 113. Bristol Myers Squibb Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Bristol Myers Squibb Main Business
Table 115. Bristol Myers Squibb Latest Developments
Table 116. Celgene Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. Celgene Oncology Therapeutic Drug Product Portfolios and Specifications
Table 118. Celgene Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. Celgene Main Business
Table 120. Celgene Latest Developments
Table 121. Eisai Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 122. Eisai Oncology Therapeutic Drug Product Portfolios and Specifications
Table 123. Eisai Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Eisai Main Business
Table 125. Eisai Latest Developments
Table 126. Eli Lilly and Company Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 127. Eli Lilly and Company Oncology Therapeutic Drug Product Portfolios and Specifications
Table 128. Eli Lilly and Company Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Eli Lilly and Company Main Business
Table 130. Eli Lilly and Company Latest Developments
Table 131. Gilead Sciences Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 132. Gilead Sciences Oncology Therapeutic Drug Product Portfolios and Specifications
Table 133. Gilead Sciences Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Gilead Sciences Main Business
Table 135. Gilead Sciences Latest Developments
Table 136. Ipsen Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 137. Ipsen Oncology Therapeutic Drug Product Portfolios and Specifications
Table 138. Ipsen Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. Ipsen Main Business
Table 140. Ipsen Latest Developments
Table 141. Johnson and Johnson Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 142. Johnson and Johnson Oncology Therapeutic Drug Product Portfolios and Specifications
Table 143. Johnson and Johnson Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 144. Johnson and Johnson Main Business
Table 145. Johnson and Johnson Latest Developments
Table 146. Merck Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 147. Merck Oncology Therapeutic Drug Product Portfolios and Specifications
Table 148. Merck Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 149. Merck Main Business
Table 150. Merck Latest Developments
Table 151. Novartis Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 152. Novartis Oncology Therapeutic Drug Product Portfolios and Specifications
Table 153. Novartis Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 154. Novartis Main Business
Table 155. Novartis Latest Developments
Table 156. Otsuka Pharmaceutical Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 157. Otsuka Pharmaceutical Oncology Therapeutic Drug Product Portfolios and Specifications
Table 158. Otsuka Pharmaceutical Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 159. Otsuka Pharmaceutical Main Business
Table 160. Otsuka Pharmaceutical Latest Developments
Table 161. Pfizer Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 162. Pfizer Oncology Therapeutic Drug Product Portfolios and Specifications
Table 163. Pfizer Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 164. Pfizer Main Business
Table 165. Pfizer Latest Developments
Table 166. F. Hoffmann-La Roche Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 167. F. Hoffmann-La Roche Oncology Therapeutic Drug Product Portfolios and Specifications
Table 168. F. Hoffmann-La Roche Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 169. F. Hoffmann-La Roche Main Business
Table 170. F. Hoffmann-La Roche Latest Developments
Table 171. Sanofi Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 172. Sanofi Oncology Therapeutic Drug Product Portfolios and Specifications
Table 173. Sanofi Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 174. Sanofi Main Business
Table 175. Sanofi Latest Developments
Table 176. Takeda Pharmaceutical Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 177. Takeda Pharmaceutical Oncology Therapeutic Drug Product Portfolios and Specifications
Table 178. Takeda Pharmaceutical Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 179. Takeda Pharmaceutical Main Business
Table 180. Takeda Pharmaceutical Latest Developments
Table 181. Teva Pharmaceutical Industries Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 182. Teva Pharmaceutical Industries Oncology Therapeutic Drug Product Portfolios and Specifications
Table 183. Teva Pharmaceutical Industries Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 184. Teva Pharmaceutical Industries Main Business
Table 185. Teva Pharmaceutical Industries Latest Developments
Table 1. Oncology Therapeutic Drug Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Oncology Therapeutic Drug Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Chemotherapy
Table 4. Major Players of Targeted Therapy
Table 5. Major Players of Immunotherapy
Table 6. Major Players of Hormonal Therapy
Table 7. Major Players of Others
Table 8. Global Oncology Therapeutic Drug Sales by Type (2018-2023) & (K Units)
Table 9. Global Oncology Therapeutic Drug Sales Market Share by Type (2018-2023)
Table 10. Global Oncology Therapeutic Drug Revenue by Type (2018-2023) & ($ million)
Table 11. Global Oncology Therapeutic Drug Revenue Market Share by Type (2018-2023)
Table 12. Global Oncology Therapeutic Drug Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Oncology Therapeutic Drug Sales by Application (2018-2023) & (K Units)
Table 14. Global Oncology Therapeutic Drug Sales Market Share by Application (2018-2023)
Table 15. Global Oncology Therapeutic Drug Revenue by Application (2018-2023)
Table 16. Global Oncology Therapeutic Drug Revenue Market Share by Application (2018-2023)
Table 17. Global Oncology Therapeutic Drug Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Oncology Therapeutic Drug Sales by Company (2018-2023) & (K Units)
Table 19. Global Oncology Therapeutic Drug Sales Market Share by Company (2018-2023)
Table 20. Global Oncology Therapeutic Drug Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Oncology Therapeutic Drug Revenue Market Share by Company (2018-2023)
Table 22. Global Oncology Therapeutic Drug Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Oncology Therapeutic Drug Producing Area Distribution and Sales Area
Table 24. Players Oncology Therapeutic Drug Products Offered
Table 25. Oncology Therapeutic Drug Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Oncology Therapeutic Drug Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Oncology Therapeutic Drug Sales Market Share Geographic Region (2018-2023)
Table 30. Global Oncology Therapeutic Drug Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Oncology Therapeutic Drug Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Oncology Therapeutic Drug Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Oncology Therapeutic Drug Sales Market Share by Country/Region (2018-2023)
Table 34. Global Oncology Therapeutic Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Oncology Therapeutic Drug Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Oncology Therapeutic Drug Sales by Country (2018-2023) & (K Units)
Table 37. Americas Oncology Therapeutic Drug Sales Market Share by Country (2018-2023)
Table 38. Americas Oncology Therapeutic Drug Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Oncology Therapeutic Drug Revenue Market Share by Country (2018-2023)
Table 40. Americas Oncology Therapeutic Drug Sales by Type (2018-2023) & (K Units)
Table 41. Americas Oncology Therapeutic Drug Sales by Application (2018-2023) & (K Units)
Table 42. APAC Oncology Therapeutic Drug Sales by Region (2018-2023) & (K Units)
Table 43. APAC Oncology Therapeutic Drug Sales Market Share by Region (2018-2023)
Table 44. APAC Oncology Therapeutic Drug Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Oncology Therapeutic Drug Revenue Market Share by Region (2018-2023)
Table 46. APAC Oncology Therapeutic Drug Sales by Type (2018-2023) & (K Units)
Table 47. APAC Oncology Therapeutic Drug Sales by Application (2018-2023) & (K Units)
Table 48. Europe Oncology Therapeutic Drug Sales by Country (2018-2023) & (K Units)
Table 49. Europe Oncology Therapeutic Drug Sales Market Share by Country (2018-2023)
Table 50. Europe Oncology Therapeutic Drug Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Oncology Therapeutic Drug Revenue Market Share by Country (2018-2023)
Table 52. Europe Oncology Therapeutic Drug Sales by Type (2018-2023) & (K Units)
Table 53. Europe Oncology Therapeutic Drug Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Oncology Therapeutic Drug Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Oncology Therapeutic Drug Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Oncology Therapeutic Drug Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Oncology Therapeutic Drug Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Oncology Therapeutic Drug Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Oncology Therapeutic Drug Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Oncology Therapeutic Drug
Table 61. Key Market Challenges & Risks of Oncology Therapeutic Drug
Table 62. Key Industry Trends of Oncology Therapeutic Drug
Table 63. Oncology Therapeutic Drug Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Oncology Therapeutic Drug Distributors List
Table 66. Oncology Therapeutic Drug Customer List
Table 67. Global Oncology Therapeutic Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Oncology Therapeutic Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Oncology Therapeutic Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Oncology Therapeutic Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Oncology Therapeutic Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Oncology Therapeutic Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Oncology Therapeutic Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Oncology Therapeutic Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Oncology Therapeutic Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Oncology Therapeutic Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Oncology Therapeutic Drug Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Oncology Therapeutic Drug Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Oncology Therapeutic Drug Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Oncology Therapeutic Drug Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. AbbVie Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. AbbVie Oncology Therapeutic Drug Product Portfolios and Specifications
Table 83. AbbVie Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. AbbVie Main Business
Table 85. AbbVie Latest Developments
Table 86. Amgen Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Amgen Oncology Therapeutic Drug Product Portfolios and Specifications
Table 88. Amgen Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Amgen Main Business
Table 90. Amgen Latest Developments
Table 91. Astellas Pharma Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. Astellas Pharma Oncology Therapeutic Drug Product Portfolios and Specifications
Table 93. Astellas Pharma Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Astellas Pharma Main Business
Table 95. Astellas Pharma Latest Developments
Table 96. AstraZeneca Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. AstraZeneca Oncology Therapeutic Drug Product Portfolios and Specifications
Table 98. AstraZeneca Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. AstraZeneca Main Business
Table 100. AstraZeneca Latest Developments
Table 101. Bayer Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. Bayer Oncology Therapeutic Drug Product Portfolios and Specifications
Table 103. Bayer Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Bayer Main Business
Table 105. Bayer Latest Developments
Table 106. Biogen Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Biogen Oncology Therapeutic Drug Product Portfolios and Specifications
Table 108. Biogen Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Biogen Main Business
Table 110. Biogen Latest Developments
Table 111. Bristol Myers Squibb Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. Bristol Myers Squibb Oncology Therapeutic Drug Product Portfolios and Specifications
Table 113. Bristol Myers Squibb Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Bristol Myers Squibb Main Business
Table 115. Bristol Myers Squibb Latest Developments
Table 116. Celgene Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. Celgene Oncology Therapeutic Drug Product Portfolios and Specifications
Table 118. Celgene Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. Celgene Main Business
Table 120. Celgene Latest Developments
Table 121. Eisai Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 122. Eisai Oncology Therapeutic Drug Product Portfolios and Specifications
Table 123. Eisai Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Eisai Main Business
Table 125. Eisai Latest Developments
Table 126. Eli Lilly and Company Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 127. Eli Lilly and Company Oncology Therapeutic Drug Product Portfolios and Specifications
Table 128. Eli Lilly and Company Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Eli Lilly and Company Main Business
Table 130. Eli Lilly and Company Latest Developments
Table 131. Gilead Sciences Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 132. Gilead Sciences Oncology Therapeutic Drug Product Portfolios and Specifications
Table 133. Gilead Sciences Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Gilead Sciences Main Business
Table 135. Gilead Sciences Latest Developments
Table 136. Ipsen Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 137. Ipsen Oncology Therapeutic Drug Product Portfolios and Specifications
Table 138. Ipsen Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. Ipsen Main Business
Table 140. Ipsen Latest Developments
Table 141. Johnson and Johnson Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 142. Johnson and Johnson Oncology Therapeutic Drug Product Portfolios and Specifications
Table 143. Johnson and Johnson Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 144. Johnson and Johnson Main Business
Table 145. Johnson and Johnson Latest Developments
Table 146. Merck Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 147. Merck Oncology Therapeutic Drug Product Portfolios and Specifications
Table 148. Merck Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 149. Merck Main Business
Table 150. Merck Latest Developments
Table 151. Novartis Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 152. Novartis Oncology Therapeutic Drug Product Portfolios and Specifications
Table 153. Novartis Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 154. Novartis Main Business
Table 155. Novartis Latest Developments
Table 156. Otsuka Pharmaceutical Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 157. Otsuka Pharmaceutical Oncology Therapeutic Drug Product Portfolios and Specifications
Table 158. Otsuka Pharmaceutical Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 159. Otsuka Pharmaceutical Main Business
Table 160. Otsuka Pharmaceutical Latest Developments
Table 161. Pfizer Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 162. Pfizer Oncology Therapeutic Drug Product Portfolios and Specifications
Table 163. Pfizer Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 164. Pfizer Main Business
Table 165. Pfizer Latest Developments
Table 166. F. Hoffmann-La Roche Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 167. F. Hoffmann-La Roche Oncology Therapeutic Drug Product Portfolios and Specifications
Table 168. F. Hoffmann-La Roche Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 169. F. Hoffmann-La Roche Main Business
Table 170. F. Hoffmann-La Roche Latest Developments
Table 171. Sanofi Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 172. Sanofi Oncology Therapeutic Drug Product Portfolios and Specifications
Table 173. Sanofi Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 174. Sanofi Main Business
Table 175. Sanofi Latest Developments
Table 176. Takeda Pharmaceutical Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 177. Takeda Pharmaceutical Oncology Therapeutic Drug Product Portfolios and Specifications
Table 178. Takeda Pharmaceutical Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 179. Takeda Pharmaceutical Main Business
Table 180. Takeda Pharmaceutical Latest Developments
Table 181. Teva Pharmaceutical Industries Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 182. Teva Pharmaceutical Industries Oncology Therapeutic Drug Product Portfolios and Specifications
Table 183. Teva Pharmaceutical Industries Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 184. Teva Pharmaceutical Industries Main Business
Table 185. Teva Pharmaceutical Industries Latest Developments
LIST OF FIGURES
Figure 1. Picture of Oncology Therapeutic Drug
Figure 2. Oncology Therapeutic Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oncology Therapeutic Drug Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Oncology Therapeutic Drug Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Oncology Therapeutic Drug Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Chemotherapy
Figure 10. Product Picture of Targeted Therapy
Figure 11. Product Picture of Immunotherapy
Figure 12. Product Picture of Hormonal Therapy
Figure 13. Product Picture of Others
Figure 14. Global Oncology Therapeutic Drug Sales Market Share by Type in 2022
Figure 15. Global Oncology Therapeutic Drug Revenue Market Share by Type (2018-2023)
Figure 16. Oncology Therapeutic Drug Consumed in Breast Cancer
Figure 17. Global Oncology Therapeutic Drug Market: Breast Cancer (2018-2023) & (K Units)
Figure 18. Oncology Therapeutic Drug Consumed in Gastrointestinal Cancer
Figure 19. Global Oncology Therapeutic Drug Market: Gastrointestinal Cancer (2018-2023) & (K Units)
Figure 20. Oncology Therapeutic Drug Consumed in Prostate Cancer
Figure 21. Global Oncology Therapeutic Drug Market: Prostate Cancer (2018-2023) & (K Units)
Figure 22. Oncology Therapeutic Drug Consumed in Respiratory and Lung Cancer
Figure 23. Global Oncology Therapeutic Drug Market: Respiratory and Lung Cancer (2018-2023) & (K Units)
Figure 24. Oncology Therapeutic Drug Consumed in Others
Figure 25. Global Oncology Therapeutic Drug Market: Others (2018-2023) & (K Units)
Figure 26. Global Oncology Therapeutic Drug Sales Market Share by Application (2022)
Figure 27. Global Oncology Therapeutic Drug Revenue Market Share by Application in 2022
Figure 28. Oncology Therapeutic Drug Sales Market by Company in 2022 (K Units)
Figure 29. Global Oncology Therapeutic Drug Sales Market Share by Company in 2022
Figure 30. Oncology Therapeutic Drug Revenue Market by Company in 2022 ($ Million)
Figure 31. Global Oncology Therapeutic Drug Revenue Market Share by Company in 2022
Figure 32. Global Oncology Therapeutic Drug Sales Market Share by Geographic Region (2018-2023)
Figure 33. Global Oncology Therapeutic Drug Revenue Market Share by Geographic Region in 2022
Figure 34. Americas Oncology Therapeutic Drug Sales 2018-2023 (K Units)
Figure 35. Americas Oncology Therapeutic Drug Revenue 2018-2023 ($ Millions)
Figure 36. APAC Oncology Therapeutic Drug Sales 2018-2023 (K Units)
Figure 37. APAC Oncology Therapeutic Drug Revenue 2018-2023 ($ Millions)
Figure 38. Europe Oncology Therapeutic Drug Sales 2018-2023 (K Units)
Figure 39. Europe Oncology Therapeutic Drug Revenue 2018-2023 ($ Millions)
Figure 40. Middle East & Africa Oncology Therapeutic Drug Sales 2018-2023 (K Units)
Figure 41. Middle East & Africa Oncology Therapeutic Drug Revenue 2018-2023 ($ Millions)
Figure 42. Americas Oncology Therapeutic Drug Sales Market Share by Country in 2022
Figure 43. Americas Oncology Therapeutic Drug Revenue Market Share by Country in 2022
Figure 44. Americas Oncology Therapeutic Drug Sales Market Share by Type (2018-2023)
Figure 45. Americas Oncology Therapeutic Drug Sales Market Share by Application (2018-2023)
Figure 46. United States Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 47. Canada Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 48. Mexico Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 49. Brazil Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 50. APAC Oncology Therapeutic Drug Sales Market Share by Region in 2022
Figure 51. APAC Oncology Therapeutic Drug Revenue Market Share by Regions in 2022
Figure 52. APAC Oncology Therapeutic Drug Sales Market Share by Type (2018-2023)
Figure 53. APAC Oncology Therapeutic Drug Sales Market Share by Application (2018-2023)
Figure 54. China Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 55. Japan Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 56. South Korea Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 57. Southeast Asia Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 58. India Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 59. Australia Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 60. China Taiwan Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 61. Europe Oncology Therapeutic Drug Sales Market Share by Country in 2022
Figure 62. Europe Oncology Therapeutic Drug Revenue Market Share by Country in 2022
Figure 63. Europe Oncology Therapeutic Drug Sales Market Share by Type (2018-2023)
Figure 64. Europe Oncology Therapeutic Drug Sales Market Share by Application (2018-2023)
Figure 65. Germany Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 66. France Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 67. UK Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 68. Italy Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 69. Russia Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 70. Middle East & Africa Oncology Therapeutic Drug Sales Market Share by Country in 2022
Figure 71. Middle East & Africa Oncology Therapeutic Drug Revenue Market Share by Country in 2022
Figure 72. Middle East & Africa Oncology Therapeutic Drug Sales Market Share by Type (2018-2023)
Figure 73. Middle East & Africa Oncology Therapeutic Drug Sales Market Share by Application (2018-2023)
Figure 74. Egypt Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 75. South Africa Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 76. Israel Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 77. Turkey Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 78. GCC Country Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Oncology Therapeutic Drug in 2022
Figure 80. Manufacturing Process Analysis of Oncology Therapeutic Drug
Figure 81. Industry Chain Structure of Oncology Therapeutic Drug
Figure 82. Channels of Distribution
Figure 83. Global Oncology Therapeutic Drug Sales Market Forecast by Region (2024-2029)
Figure 84. Global Oncology Therapeutic Drug Revenue Market Share Forecast by Region (2024-2029)
Figure 85. Global Oncology Therapeutic Drug Sales Market Share Forecast by Type (2024-2029)
Figure 86. Global Oncology Therapeutic Drug Revenue Market Share Forecast by Type (2024-2029)
Figure 87. Global Oncology Therapeutic Drug Sales Market Share Forecast by Application (2024-2029)
Figure 88. Global Oncology Therapeutic Drug Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Oncology Therapeutic Drug
Figure 2. Oncology Therapeutic Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oncology Therapeutic Drug Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Oncology Therapeutic Drug Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Oncology Therapeutic Drug Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Chemotherapy
Figure 10. Product Picture of Targeted Therapy
Figure 11. Product Picture of Immunotherapy
Figure 12. Product Picture of Hormonal Therapy
Figure 13. Product Picture of Others
Figure 14. Global Oncology Therapeutic Drug Sales Market Share by Type in 2022
Figure 15. Global Oncology Therapeutic Drug Revenue Market Share by Type (2018-2023)
Figure 16. Oncology Therapeutic Drug Consumed in Breast Cancer
Figure 17. Global Oncology Therapeutic Drug Market: Breast Cancer (2018-2023) & (K Units)
Figure 18. Oncology Therapeutic Drug Consumed in Gastrointestinal Cancer
Figure 19. Global Oncology Therapeutic Drug Market: Gastrointestinal Cancer (2018-2023) & (K Units)
Figure 20. Oncology Therapeutic Drug Consumed in Prostate Cancer
Figure 21. Global Oncology Therapeutic Drug Market: Prostate Cancer (2018-2023) & (K Units)
Figure 22. Oncology Therapeutic Drug Consumed in Respiratory and Lung Cancer
Figure 23. Global Oncology Therapeutic Drug Market: Respiratory and Lung Cancer (2018-2023) & (K Units)
Figure 24. Oncology Therapeutic Drug Consumed in Others
Figure 25. Global Oncology Therapeutic Drug Market: Others (2018-2023) & (K Units)
Figure 26. Global Oncology Therapeutic Drug Sales Market Share by Application (2022)
Figure 27. Global Oncology Therapeutic Drug Revenue Market Share by Application in 2022
Figure 28. Oncology Therapeutic Drug Sales Market by Company in 2022 (K Units)
Figure 29. Global Oncology Therapeutic Drug Sales Market Share by Company in 2022
Figure 30. Oncology Therapeutic Drug Revenue Market by Company in 2022 ($ Million)
Figure 31. Global Oncology Therapeutic Drug Revenue Market Share by Company in 2022
Figure 32. Global Oncology Therapeutic Drug Sales Market Share by Geographic Region (2018-2023)
Figure 33. Global Oncology Therapeutic Drug Revenue Market Share by Geographic Region in 2022
Figure 34. Americas Oncology Therapeutic Drug Sales 2018-2023 (K Units)
Figure 35. Americas Oncology Therapeutic Drug Revenue 2018-2023 ($ Millions)
Figure 36. APAC Oncology Therapeutic Drug Sales 2018-2023 (K Units)
Figure 37. APAC Oncology Therapeutic Drug Revenue 2018-2023 ($ Millions)
Figure 38. Europe Oncology Therapeutic Drug Sales 2018-2023 (K Units)
Figure 39. Europe Oncology Therapeutic Drug Revenue 2018-2023 ($ Millions)
Figure 40. Middle East & Africa Oncology Therapeutic Drug Sales 2018-2023 (K Units)
Figure 41. Middle East & Africa Oncology Therapeutic Drug Revenue 2018-2023 ($ Millions)
Figure 42. Americas Oncology Therapeutic Drug Sales Market Share by Country in 2022
Figure 43. Americas Oncology Therapeutic Drug Revenue Market Share by Country in 2022
Figure 44. Americas Oncology Therapeutic Drug Sales Market Share by Type (2018-2023)
Figure 45. Americas Oncology Therapeutic Drug Sales Market Share by Application (2018-2023)
Figure 46. United States Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 47. Canada Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 48. Mexico Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 49. Brazil Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 50. APAC Oncology Therapeutic Drug Sales Market Share by Region in 2022
Figure 51. APAC Oncology Therapeutic Drug Revenue Market Share by Regions in 2022
Figure 52. APAC Oncology Therapeutic Drug Sales Market Share by Type (2018-2023)
Figure 53. APAC Oncology Therapeutic Drug Sales Market Share by Application (2018-2023)
Figure 54. China Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 55. Japan Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 56. South Korea Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 57. Southeast Asia Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 58. India Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 59. Australia Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 60. China Taiwan Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 61. Europe Oncology Therapeutic Drug Sales Market Share by Country in 2022
Figure 62. Europe Oncology Therapeutic Drug Revenue Market Share by Country in 2022
Figure 63. Europe Oncology Therapeutic Drug Sales Market Share by Type (2018-2023)
Figure 64. Europe Oncology Therapeutic Drug Sales Market Share by Application (2018-2023)
Figure 65. Germany Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 66. France Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 67. UK Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 68. Italy Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 69. Russia Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 70. Middle East & Africa Oncology Therapeutic Drug Sales Market Share by Country in 2022
Figure 71. Middle East & Africa Oncology Therapeutic Drug Revenue Market Share by Country in 2022
Figure 72. Middle East & Africa Oncology Therapeutic Drug Sales Market Share by Type (2018-2023)
Figure 73. Middle East & Africa Oncology Therapeutic Drug Sales Market Share by Application (2018-2023)
Figure 74. Egypt Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 75. South Africa Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 76. Israel Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 77. Turkey Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 78. GCC Country Oncology Therapeutic Drug Revenue Growth 2018-2023 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Oncology Therapeutic Drug in 2022
Figure 80. Manufacturing Process Analysis of Oncology Therapeutic Drug
Figure 81. Industry Chain Structure of Oncology Therapeutic Drug
Figure 82. Channels of Distribution
Figure 83. Global Oncology Therapeutic Drug Sales Market Forecast by Region (2024-2029)
Figure 84. Global Oncology Therapeutic Drug Revenue Market Share Forecast by Region (2024-2029)
Figure 85. Global Oncology Therapeutic Drug Sales Market Share Forecast by Type (2024-2029)
Figure 86. Global Oncology Therapeutic Drug Revenue Market Share Forecast by Type (2024-2029)
Figure 87. Global Oncology Therapeutic Drug Sales Market Share Forecast by Application (2024-2029)
Figure 88. Global Oncology Therapeutic Drug Revenue Market Share Forecast by Application (2024-2029)
